Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ricky Y.T. Chiu"'
Autor:
Sean Parkin, Raymond Wai-Hung Yung, Matthew Brobeck, Mei Wai Fung, Jeffrey D. Klausner, Dan MArshak, Stephen Ka-Kung Ho, Eric Tsang, Ryan Siu, Jessica Pui Ling Ng, Tsz Hei Choi, Jonpaul Sze-Tsing Zee, Ricky Y.T. Chiu, Koon Kung Lee, Edmond S. K. Ma, Alex Chin-Pang Leung, Felix C. Chao, Tenny Chung, Tsun Leung Chan, Kwok Kin Cheng, Noah Kojima, Garrett L. Mosley, David Y. Pereira, Wai Sing Chan, Harsha Kittur, Ho Yin Lam, Kajal Maran
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 1 (2021)
Microbiology Spectrum
Microbiology Spectrum
As the COVID-19 pandemic progresses, there is an increasing need for rapid, accessible assays for SARS-CoV-2 detection. We present a clinical evaluation and real-world implementation of the INDICAID COVID-19 rapid antigen test (INDICAID rapid test).
Autor:
Daniel R. Marshak, Masae Kobayashi, Filip Janku, Felix C. Chao, S. Greg Call, Chung Hei Chiu, Kristen T. Woodbury, Helen J. Huang, David Y. Pereira, Ricky Y.T. Chiu
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Low yields of extracted cell-free DNA (cfDNA) from plasma limit continued development of liquid biopsy in cancer, especially in early-stage cancer diagnostics and cancer screening applications. We investigate a novel liquid-phase-based DNA isolation
Autor:
Ricky Y.T. Chiu, Daniel R. Marshak, Masae Kobayashi, Steven G. Call, David Y. Pereira, Felix C. Chao, Helen J. Huang, Kristen T. Woodbury, Filip Janku
Publikováno v:
Cancer Research. 81:575-575
Background: Low yields of extracted cell-free DNA (cfDNA) from plasma limit further development of liquid biopsies for early-stage cancer diagnostics and cancer screening applications. Conventional nucleic acid extraction methods have limitations in
Autor:
Steven G. Call, Felix C. Chao, Chung Hei Chiu, Filip Janku, Kristen T. Woodbury, David Y. Pereira, Ricky Y.T. Chiu, Daniel R. Marshak, Helen J. Huang, Masae Kobayashi
Publikováno v:
Cancer Research. 80:1979-1979
Background: Low yields of extracted cell-free DNA (cfDNA) from plasma limit further development of liquid biopsies especially in early-stage cancer diagnostics and cancer screening applications. We developed a novel liquid-liquid based DNA isolation
Autor:
Anthony D. Cristillo, Barbara Van Der Pol, Rosanna W. Peeling, Nitika Pant Pai, Catherine M. Klapperich, Sasha Herbst de Cortina, Sheldon R. Morris, Ricky Y.T. Chiu, Claire C. Bristow, Purnima Madhivanan, Jeffrey D. Klausner, Dong Jin Shin, Ivan Dimov
The goal of the point-of-care (POC) sexually transmitted infection (STI) Diagnostics meeting was to review the state-of-the-art research and develop recommendations for the use of POC STI diagnostics. Experts from academia, government, nonprofit, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95dc7c045888a4343e44fb4715657842
Publikováno v:
Biotechnology and Bioengineering. 111:2499-2507
The development of point-of-need (PON) diagnostics for viruses has the potential to prevent pandemics and protects against biological warfare threats. Here we discuss the approach of using aqueous two-phase systems (ATPSs) to concentrate biomolecules
Publikováno v:
PLoS ONE
PloS one, vol 10, iss 11
PLoS ONE, Vol 10, Iss 11, p e0142654 (2015)
PloS one, vol 10, iss 11
PLoS ONE, Vol 10, Iss 11, p e0142654 (2015)
The paper-based immunoassay for point-of-care diagnostics is widely used due to its low cost and portability over traditional lab-based assays. Lateral-flow immunoassay (LFA) is the most well-established paper-based assay since it is rapid and easy t
Publikováno v:
Analytica chimica acta. 882
The lateral-flow immunoassay (LFA) is an inexpensive and rapid paper-based assay that can potentially detect infectious disease biomarkers in resource-poor settings. Despite its many advantages that make it suitable for point-of-care diagnosis, LFA i
Autor:
Daniel T. Kamei, Stephanie Wang, Ricky Y.T. Chiu, Allison T. Yip, Alexandra R. Kivnick, Erik Jue, Andrew R. Berg, Phuong T. Nguyen
Publikováno v:
Lab on a chip. 14(16)
The lateral-flow immunoassay (LFA) is an inexpensive point-of-care (POC) paper-based diagnostic device with the potential to rapidly detect disease biomarkers in resource-poor settings. Although LFA is inexpensive, easy to use, and requires no labora
Publikováno v:
Annals of biomedical engineering. 42(11)
The lateral-flow immunoassay (LFA) is a well-established point-of-care detection assay that is rapid, inexpensive, easy to use, and portable. However, its sensitivity is lower than that of traditional lab-based assays. Previously, we improved the sen